Perfect π
Hereβs the **stylishly formatted and complete extracted text** from all the uploaded pages β neat, structured, and ready for notes or website use π
---
# π **Gestational Trophoblastic Disease (GTD)**
---
## πΈ **Classification**
**1. Molar pregnancy / Hydatidiform mole**
* Partial mole
* Complete (vesicular) mole
**2. Gestational trophoblastic neoplasia (GTN):**
* Invasive mole
* Choriocarcinoma
* Placental site trophoblastic tumour (PSTT)
* Epithelioid trophoblastic tumour (ETT)
---
## π **Molar Pregnancy**
### **Risk Factors**
* Previous history of molar pregnancy (most important)
* Southeast Asian countries
* Extremes of age
### **Pathogenesis**
* Undue proliferation of trophoblast β space for inner cell mass
* With some fetal tissue β **Partial mole**
* With no fetal tissue β **Complete mole**
* Hydropic degeneration
### **Features**
Benign disease with malignant potential
### **Symptoms**
* Bleeding PV (1st or early 2nd trimester) β m/c presentation
* Passage of grape-like vesicles PV
* Early-onset PIH (<20 weeks due to β placental tissue)
* Hyperemesis gravidarum
* Thyrotoxicosis
* Bilateral theca lutein cysts (β hCG)
* Pulmonary embolism
* Breathlessness
---
## π©Ά **Signs**
**Per abdomen:**
* Fundal height > period of gestation (rarely β€ POG)
* Fetal parts not palpable
* Fetal heart sounds absent
* Doughy uterine consistency
---
## π©Ί **Management**
### **Investigations**
* **USG:** Snowstorm appearance (IOC)
* Ξ²-hCG
* Blood group & Rh typing
* CBC
* LFT, KFT
* Chest X-ray
* TFT
### **Treatment**
1. **Suction evacuation** β followed by **sharp curettage**
* β οΈ Risk: Thyrotoxicosis / thyroid storm, Pulmonary embolism
* Oxytocin given after starting suction
2. **Hysterectomy:**
* Indicated if β₯40 yrs & family completed
### **Post-op**
* Send specimen for histopathology
### **Follow-up**
* Ξ²-hCG levels β IOC for monitoring
**Procedure:**
1. Baseline Ξ²-hCG (before)
2. 48 hrs after evacuation
3. Weekly Ξ²-hCG till 3 consecutive normal values (<5 IU/L)
4. Monthly Ξ²-hCG till 6 months
**Advice:**
* Pregnancy contraindicated for 6 months
* Contraceptives:
* OCP β
(choice)
* IUCD β (contraindicated)
---
## 𧬠**Partial vs Complete Mole**
| Feature | Partial Mole | Complete Mole |
| --------------------------- | ---------------------------------------------------- | -------------------------------------------------------- |
| **Pathogenesis** | 1 ovum + 2 sperms | Empty ovum (no maternal genes) + 2 sperms |
| **Karyotype** | Triploid (69, XXY m/c, 69 XXX) | Diploid (46, XX) |
| **No. of sperms** | Dispermic | Monospermic |
| **Maternal genes** | Present | Absent |
| **p57 Kipa staining** | (+) | (β) |
| **Symptoms** | Less common | More common |
| **Height of uterus** | β€ POG | > POG |
| **USG (IOC)** | Cystic spaces, fetus present, β amniotic fluid | Snowstorm appearance, no fetus, b/l theca lutein cysts |
| **HPE** | Some fetal tissue, vascular villi, mild degeneration | No fetal tissue, avascular villi, extensive degeneration |
| **Subsequent GTN** | 1% | 15β20% |
| **Risk of choriocarcinoma** | <1% | 4% |
| **Return of Ξ²-hCG** | 6 weeks | 7 weeks |
| **Ξ²-hCG level** | <10β΅ IU/L | β₯10β΅ IU/L |
---
## πΊ **Gestational Trophoblastic Neoplasia (GTN)**
### **Causes**
| Cause | Invasive Mole | PSTT | Choriocarcinoma |
| ------------------- | ------------- | ---- | --------------- |
| Molar pregnancy | (+) | (β) | (+) |
| Full-term pregnancy | (β) | (+) | (+) |
| Ectopic pregnancy | (β) | (β) | (+) |
| Abortion | (β) | (β) | (+) |
---
## βοΈ **Clinical Features (Post-molar pregnancy)**
**Symptoms:**
* Persistent bleeding PV
* Persistent theca lutein cyst
* Subinvolution of uterus
* Shock (due to invasive mole)
* Metastasis
**Lab criteria:**
* Ξ²-hCG plateau for 4 weeks (Β±10% of prev. value) β invasive mole
* Ξ²-hCG β β₯10% for 3 weeks β choriocarcinoma
* Ξ²-hCG present after 6 months β persistent GTN
* HPE proven
**Metastases:**
* **Lung:** m/c site β Stage 3
* CXR: Cannon ball / snowstorm appearance
* **Vagina:** Suburethral nodules (2nd m/c site)
* Biopsy contraindicated
---
## βοΈ **Staging & Scoring**
### **FIGO Staging**
| Stage | Characteristics |
| ----- | ------------------------- |
| I | Limited to uterus |
| II | Pelvic organs involved |
| III | Lung metastasis |
| IV | Brain or liver metastasis |
### **WHO Risk Scoring**
| Parameter | Low Risk | High Risk |
| -------------------- | ----------- | ----------- |
| Age | <40 yrs | β₯40 yrs |
| Antecedent pregnancy | Molar | Full-term |
| Interval | <4 months | β₯4 months |
| hCG | <10Β³ IU/L | β₯10β΅ IU/L |
| Tumour size | <3 cm | β₯5 cm |
| Site | Lung/Vagina | Brain/Liver |
| No. of metastases | <4 | >8 |
| Failed chemo | (β) | (+) |
**Total score:**
* β€6 β Low-risk GTN
* β₯7 β High-risk GTN
---
## π **Management of GTN**
**GTN is chemosensitive.**
| Stage | Risk | Management |
| ------ | --------- | ----------------- |
| I | Low-risk | Methotrexate |
| IIβIII | Low (<6) | Methotrexate |
| IIβIII | High (β₯7) | Multidrug (EMACO) |
| IV | High | Chemotherapy |
---
## π **Chemotherapy Regimens**
### **Single Drug Therapy (Low Risk)**
* **Methotrexate (MTX):** DOC
* Equally divided doses on days 1, 3, 5, 7
* Alternate with folinic acid
* Check Ξ²-hCG β repeat till 3 consecutive normal values
* Follow-up 12 months
### **Multidrug Therapy (High Risk)**
**EMACO (Bagshaw Regimen):**
* E: Etoposide (Day 1)
* M: Methotrexate (Day 2)
* A: Actinomycin D (Day 3)
* C: Cyclophosphamide (Day 4)
* O: Oncovin (Vincristine) (Day 5)
If resistant β EMAEP (Etoposide + Cisplatin added)
---
## β‘ **Radiotherapy**
* Indicated for **brain metastasis**
---
## π§« **Management of PSTT / ETT**
* **Hysterectomy** β followed by **EMACO**
* **Tumour markers:**
* PSTT β Placental alkaline phosphatase
* ETT β Human placental lactogen
**Indications for hysterectomy in GTD:**
* Molar pregnancy β₯40 years + completed family
* Intractable hemorrhage during evacuation
* PSTT or ETT
* Stage I GTN + completed family (hysterectomy + MTX)
---
## π¬ **Histopathological Comparison**
| Feature | Invasive Mole | Choriocarcinoma | PSTT |
| ----------------- | ------------------------------------- | --------------- | ------------------------ |
| Villous structure | Edematous chorionic villi | Absent | Absent |
| Cell types | Syncytiotrophoblast + cytotrophoblast | Same | Intermediate trophoblast |
---
### β
**Follow-Up Summary**
* Ξ²-hCG: Weekly till normal (Γ3), then monthly Γ6β12 months
* Pregnancy contraindicated Γ12 months
* Use OCPs for contraception
---
Would you like me to now **make 20 hard case-based MCQs** (with explanation + HTML/CSS/JS interactive quiz format) on this entire *Gestational Trophoblastic Disease* topic?